Sponsored by
 |
Thursday, October 23
10-10:50am
Location: Casanova 601
An FDA Update on Dietary Supplement Regulation, GMP Compliance and Adverse Event Reporting
Join Dr. Vasilios H. Frankos, director of FDA’s Division of Dietary
Supplement Programs, as he provides an update on recent FDA activity.
The discussion will include an update on dietary supplement regulation,
GMP compliance and adverse event reporting.
Speaker:
 Vasilios H. Frankos, Ph.D., serves as the
director, Division of Dietary Supplement Programs (DDSP) for FDA. Dr.
Frankos directs and coordinates policy, budget, personnel and
administrative activities within the division. He advises on policy and
management issues and decisions, and provides expert advice and
assistance to the Office of Nutrition, Labeling, and Dietary Supplements
director, and other key FDA officials on dietary supplement
programs, new dietary ingredient safety assessments, good manufacturing
practices, adverse reaction monitoring and related activities pertaining
to dietary supplements. Dr. Frankos is responsible for the full
implementation of DSHEA through the interpretation and enforcement of
dietary supplement requirements that ensure the safety and truthful
labeling of dietary supplements, and support legislative compliance,
enforcement and public affairs initiatives. Dr. Frankos received his
master’s of science degree in molecular biology from the University of
Maryland, and his doctorate in pharmacology and toxicology from the
University of Maryland Pharmacy School. He has over 30 years of
experience in the toxicological and pharmacological evaluation of data
used to assess the safety of nutritional supplements, foods and food
additives, drugs, medical devices, cosmetics and environmental
chemicals.
|
